Daratumumab treatment shows promise for high-risk smoldering multiple myeloma in phase 3 trial Post author: Post published:December 10, 2024 Post category:uncategorized A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). You Might Also Like Who’s policing opioid settlement spending? A crowdsourced database might help July 11, 2025 Japanese researchers test cardiac spheroids for heart regeneration in monkeys April 27, 2024 Study provides insights into the challenges faced by American moms in the year after birth November 6, 2023
Study provides insights into the challenges faced by American moms in the year after birth November 6, 2023